Catalyst Wire Dossier Catalyst Wire Dossier

Pacritinib

pacritinib · CTI BioPharma
Drug timelines are a Plus or Pro feature.

37 regulatory and trial events tracked for Pacritinib, covering 2016-06-17 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Effectiveness and Safety of Pacritinib in Patients With VEXAS Syndrome (PAXIS) [Phase 2]

See pricing